Papua New Guinea vs South-East Asia (WHO region): Treatment success rate: XDR-TB cases
Papua New Guinea
100
in 2019
South-East Asia (WHO region)
73
in 2022
Papua New Guinea rank
1st
South-East Asia (WHO region) rank
2nd
Treatment success rate: XDR-TB cases over time
- Papua New Guinea
- South-East Asia (WHO region)
How they compare
Papua New Guinea currently reports 100 against 73 in South-East Asia (WHO region), a difference of 27.
That makes Papua New Guinea's figure about 1.4 times South-East Asia (WHO region)'s.
Across all 6 years both countries report, Papua New Guinea has been ahead every year.
Papua New Guinea ranks 1st and South-East Asia (WHO region) ranks 2nd of 82 countries.
Papua New Guinea has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher treatment success rate: xdr-tb cases, Papua New Guinea or South-East Asia (WHO region)?
- Papua New Guinea, at 100 against 73 in South-East Asia (WHO region) as of 2019.
- What is the difference in treatment success rate: xdr-tb cases between Papua New Guinea and South-East Asia (WHO region)?
- 27, with Papua New Guinea ahead.
- How many years of comparable data are there for Papua New Guinea and South-East Asia (WHO region)?
- 6 years are reported by both, from 2014 to 2019.
- How do Papua New Guinea and South-East Asia (WHO region) rank globally for treatment success rate: xdr-tb cases?
- Papua New Guinea ranks 1st and South-East Asia (WHO region) ranks 2nd of 82 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.